Skip to main content
Top
Published in: Journal of Nephrology 7/2023

26-06-2023 | original Article

Effects of anthropometric changes on hospitalization and mortality among patients on hemodialysis

Authors: Shun Yoshikoshi, Yuta Suzuki, Shohei Yamamoto, Keigo Imamura, Manae Harada, Shiwori Osada, Atsuhiko Matsunaga

Published in: Journal of Nephrology | Issue 7/2023

Login to get access

Abstract

Background

Low values for anthropometric indicators are risk factors for adverse clinical outcomes among patients on hemodialysis. Nonetheless, little is known about the association between the trajectory of anthropometric indicators and prognosis. We examined the association between a one-year change in anthropometric indicators and hospitalization and mortality in patients undergoing hemodialysis.

Methods

This retrospective cohort study collected data on five anthropometric indicators from patients undergoing maintenance hemodialysis: body mass index, mid-upper arm circumference, triceps skinfold, mid-arm muscle circumference, and calf circumference. We calculated their trajectories over one year. The outcomes were all-cause death and the number of all-cause hospitalizations. Negative binomial regressions were used to examine these associations.

Results

We included 283 patients (mean age, 67.3 years; 60.4% males). During the follow-up period (median, 2.7 years), 30 deaths and 200 hospitalizations occurred. Body mass index (incident rate ratio [IRR]: 0.87; 95% confidence interval [CI] 0.85–0.90), mid-upper arm circumference (IRR: 0.94; 95% CI 0.88–0.99), triceps skinfold (IRR: 0.92; 95% CI 0.84–0.99), and mid-arm muscle circumference (IRR: 0.99; 95% CI 0.98–0.99) increases over one year were associated with a lower risk of all-cause hospitalizations and death regardless of their value at any one point in time. However, the calf circumference trajectory was not associated with clinical events (IRR: 0.94; 95% CI 0.83–1.07).

Conclusions

Body mass index, mid-upper arm circumference, triceps skinfold, and mid-arm muscle circumference trajectories were independently associated with clinical events. Routinely assessing these simple measures in clinical practice may provide additional prognostic information for managing patients undergoing hemodialysis.

Graphical abstract

Appendix
Available only for authorised users
Literature
20.
go back to reference Kalantar-Zadeh K, Streja E, Molnar MZ, Lukowsky LR, Krishnan M, Kovesdy CP et al (2012) Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Atablem J Epidemiol 175:793–803. https://doi.org/10.1093/aje/kwr384CrossRef Kalantar-Zadeh K, Streja E, Molnar MZ, Lukowsky LR, Krishnan M, Kovesdy CP et al (2012) Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Atablem J Epidemiol 175:793–803. https://​doi.​org/​10.​1093/​aje/​kwr384CrossRef
27.
Metadata
Title
Effects of anthropometric changes on hospitalization and mortality among patients on hemodialysis
Authors
Shun Yoshikoshi
Yuta Suzuki
Shohei Yamamoto
Keigo Imamura
Manae Harada
Shiwori Osada
Atsuhiko Matsunaga
Publication date
26-06-2023
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 7/2023
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-023-01678-w

Other articles of this Issue 7/2023

Journal of Nephrology 7/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.